Genetic Differences In Delta 9-Tetrahydrocannabinol-Induced Facilitation

[Truth Seeker]

Abstract
Lewis, Fischer 344, and Sprague-Dawley rats were implanted with electrodes in the medial forebrain bundle and trained to lever press for brain stimulation reward using a rate-frequency curve-shift electrical brain stimulation paradigm based on a series of 16 pulse frequencies ranging from 25 to 141 Hz in descending order. Once reward thresholds were stable, rats were given 1.0 mg/kg delta 9-tetrahydrocannabinol (delta 9-THC), the psychoactive constituent in marijuana and hashish, or vehicle, by intraperitoneal injection. Lewis rats showed the most pronounced delta 9-THC-induced enhancement of brain reward functions. Sprague-Dawley rats showed an enhancement of brain reward functions that was approximately half that seen in Lewis rats. Brain reward functions in Fischer 344 rats were unaffected by delta 9-THC at the dose tested. These results are consistent with previous work showing Lewis rats to be highly sensitive to the rewarding properties of a variety of drugs of abuse, including opiates, cocaine, and alcohol, while Fischer 344 rats are relatively less sensitive. They extend such previous findings to cannabinoids, and further suggest that genetic variations to other cannabinoid effects may also exist.

Source: Genetic differences in delta 9-tetrahydrocannabinol... [Life Sci. 1996] - PubMed - NCBI

 

[Storm Crow]

The genetic differences in the human endocannabinoid system is a rapidly growing field! These may interest you!

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. (full — 2010)
A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia

A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain. (full — 2010)
A Common CNR1 (Cannabinoid Receptor 1) Haplotype Attenuates the Decrease in HDL Cholesterol That Typically Accompanies Weight Gain

The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease (full - 2010)
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease

Effects of a Commonly Occurring Genetic Polymorphism of Human CYP3A4 (I118V) on the Metabolism of Anandamide (full — 2010) Effects of a Commonly Occurring Genetic Polymorphism of Human CYP3A4 (I118V) on the Metabolism of Anandamide

G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population. (abst — 2010)
G1359A polymorphism in the cannabinoid receptor... [Arch Med Res. 2010] - PubMed - NCBI

A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands.
(abst — 2010) A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by ... - PubMed - NCBI

Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. (full — 2011) Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism

Differential signaling in human cannabinoid CB(1) receptors and their splice variants in autaptic hippocampal neurons (full — 2011)
Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones - Straiker - 2012 - British Journal of Pharmacology - Wiley Online Library

Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. (abst — 2011) Cannabinoid receptor 1 gene polymorphisms and ... [Schizophr Res. 2011] - PubMed - NCBI

Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
(abst — 2011) Unbound MEDLINE | Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. PubMed Journal article abstract

The genetic basis of the endocannabinoid system and drug addiction in humans
(abst — 2011) SAGE Journals: Your gateway to world-class journal research

Functional polymorphism in the GPR55 gene is associated with anorexia nervosa.
(abst — 2011) Functional polymorphism in the GPR55 gene is associa... [Synapse. 2011] - PubMed - NCBI

The genetics of eating disorders. (abst — 2011) The genetics of eating disorders. [Curr Top Behav Neurosci. 2011] - PubMed - NCBI

Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. (abst - 2011) Genetic association between bipolar disorder... [J Affect Disord. 2011] - PubMed - NCBI

Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women.
(abst — 2011) Endocannabinoid type 1 receptor gene (CNR... [Gynecol Endocrinol. 2011] - PubMed - NCBI

Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? (abst — 2011) Are endocannabinoid type 1 receptor gene (... [Int J Obes (Lond). 2011] - PubMed - NCBI

G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in the Chinese Han population. (abst — 2011)
G1359A polymorphism in the cannabinoid receptor-1 g... [Clin Lab. 2011] - PubMed - NCBI

Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene (abst — 2011) Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene - Otten - 2011 - Addiction Biology - Wiley Online Library

Alelle specific differences in the activity of a novel cannabinoid receptor 1(CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia and hippocampus. (full — 2012)
Alelle specific differences in the activity of a novel cannabinoid receptor 1(CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia and hippocampus.

Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives. (abst — 2012) Cannabinoid-related agents in the... [Recent Pat CNS Drug Discov. 2012] - PubMed - NCBI

Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression. (abst — 2012) Cannabinoid receptor genotype moderation... [Arch Gen Psychiatry. 2012] - PubMed - NCBI

Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome.
(abst - 2012) Irritable bowel synd... [Am J Physiol Gastrointest Liver Physiol. 2012] - PubMed - NCBI

The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention.
(abst — 2012) ScienceDirect.com - Pharmacological Research - The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention

G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes. (abst — 2012)
G1359A polymorphism in the cannabinoid recept... [J Investig Med. 2012] - PubMed - NCBI

Role of G1359A polymorphism of the cannabinoid receptor gene on weight loss and adipocytokines levels after two different hypocaloric diets. (abst — 2012)
Role of G1359A polymorphism of the cannabinoi... [J Nutr Biochem. 2012] - PubMed - NCBI

Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease. (abst — 2012) Cannabinoid receptor type 2 functional variant infl... [PLoS One. 2012] - PubMed - NCBI

Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia. (abst — 2012)
Investigation of endocannabinoid sy... [Eur Neuropsychopharmacol. 2012] - PubMed - NCBI

Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (abst — 2012) Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes

Smoking Cannabis Increases Risk of Depression in the Case of Genetic Vulnerability, Study Finds (news — 2012) Smoking cannabis increases risk of depression in the case of genetic vulnerability, study finds


Granny